Overview
- An IJN/EBU investigation reports at least 197 births tied to one Danish donor whose sperm was supplied to 67 clinics in 14 countries between 2006 and 2022.
- The donor carries a rare TP53 gene mutation found only in a subset of his sperm, which elevates cancer risk in children who inherited it.
- The European Sperm Bank was alerted in April 2020 after a cancer case but initial testing did not detect the mutation; further analyses in 2023 confirmed it and use of the donor’s sperm ceased in October 2023.
- Journalistic and medical accounts say some of the children have developed cancer and an unspecified number have died.
- The GENTURIS network called for tracing all affected families to enable genetic testing and clinical surveillance, while the sperm bank highlighted the lack of cross-border limits or tracking despite around 70,000 births facilitated over 20 years.